1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Better Plant Sciences Inc.

Better Plant Sciences Inc.

VEGGD
Better Plant Sciences Inc.US flagOther OTC
0.01
USD
- -
- -
295,925.00Market Cap
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
TTM
Revenue per Share
- -
- -
- -
0.35
0.45
0.08
0.03
0.03
0.01
Basic EPS, GAAP
- -
- -
-0.14
-1.12
-1.79
-0.68
-0.25
-0.12
-0.09
Free Cash Flow per Basic Share
- -
- -
-0.08
-0.48
-1.37
-0.49
-0.1
-0.01
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
0.23
-0.63
-0.76
-0.47
-0.49
-0.59
-0.66
Tangible Book Value per Share
- -
- -
0.31
0.15
0.12
0.1
0.08
-0.04
-0.11
Basic Weighted Avg Shares
9
9
9
9
9
13
19
20
20
Sales/Revenue/Turnover
- -
- -
- -
3
4
1
1
1
- -
Operating Margin (%)
- -
- -
- -
-207.22
-335.71
-641.98
-480.66
-161.01
-142.21
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
-1
-10
-16
-9
-5
-2
-2
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
-317.73
-398.57
-817.17
-728.74
-445.13
-884.08
Working Capital
- -
- -
3
2
- -
1
- -
-1
-2
LT Debt
- -
- -
- -
- -
- -
- -
1
1
- -
Total Equity
- -
- -
3
1
1
3
1
-1
-2
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Feb'23
May'23
Aug'23
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
20
20
20
Market Capitalization
1
- -
1

Working Capital

FRC

•

in mil. unless spec.
Feb'23
May'23
Aug'23
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
2
2
Payables & Accruals
1
1
1
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-21.99%
-155.91%
Free Cash Flow
- -
93.5%
-86.71%
Net Income, GAAP
- -
122.59%
-52.13%
Sales/Revenue/Turnover
- -
- -
-21.63%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
1
- -
- -
1
2022
- -
- -
- -
- -
1
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
0.08
0.03
-0.08
- -
-0.25
2022
-0.05
-0.04
-0.01
- -
-0.12
2023
- -
-0.01
-0.06
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Amber Allen
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
1238 Homer Street Vancouver BC Canada V6B 2Y5
IPO Date
Jan 7, 2019
Website
betterplantsciences.com
Similar Companies
Sequent Scientific Limited (SEQUENT.BO)
Aspen Pharmacare Holdings Limited (APN.JO)
Cronos Australia Limited (CAU.AX)
Aurora Cannabis Inc. R (21P.F)
BioHarvest Sciences Inc. (CNVCF)
Granules India Limited (GRANULES.BO)
Business
Better Plant Sciences Inc. develops, markets, and sells plant-based products for health and wellness in Canada and the United States. The company offers plant-based beverages consisting of cold-pressed juices, cleanses, and booster shots under the Jusu brand; plant-based personal care products, including skin care, hair care, body care, and baby care; plant-based home cleaning products; mushroom consumer products under the NeonMind brand; and plant-based frozen meals, with products sold through over 150 retail locations such as Whole Foods Market, Pharmasave, Healthy Planet, and Vitasave, as well as direct-to-consumer e-commerce platforms; it also operates Jusu Bar, a quick-serve restaurant. Better Plant Sciences maintains a portfolio of over 100 psilocybin formulas through its subsidiary Flourish Mushroom Labs, which has established Acres Flourish Labs in Saint Vincent and the Grenadines for psilocybin mushroom cultivation and R&D, and acquired a founding interest in Translational Life Sciences Inc. for biotechnology formulas involving restricted substances like cannabis and psilocybin. Founded in 2014 and headquartered at 1238 Homer Street, Vancouver, British Columbia, Canada, the company changed its name from Yield Growth Corp. in August 2020 and entered a definitive merger agreement with Metaversive in November 2023.